Press releases

December 15, 2016
Regulatory

Bactiguard enters Germany

Bactiguard has entered into partnership with Roeser Medical GmbH (“Roeser”) and signed an exclusive distribution agreement for Germany and Switzerland. At the same time, an order for products worth some EUR 400 000 has been placed and will be delivered throughout 2017. 

December 13, 2016
Regulatory

Bond loan repaid

Bactiguard outstanding bond loan was repaid in full on 12 December. The refinancing solution consists of loans totaling SEK 150 million.

December 01, 2016
Regulatory

Exercise of call options

The call option program established by the main shareholders and aimed at key individuals in Bactiguard, matured on 30 November 2016. During the exercise period, a total of 688 000 B shares were acquired, corresponding to 2.07 percent of the capital and 0.99 percent of the votes, reducing the holdings of the main shareholders accordingly.

November 18, 2016

Nomination Committee appointed for the Annual General Meeting 2017

The Annual General Meeting of Bactiguard Holding AB (publ) will be held on Thursday, 18 May 2017 in Botkyrka. 

November 10, 2016
Regulatory

Interim report for Q3 2016

In the third quarter we report a continued positive trend in sales of our own portfolio of infection prevention products for the healthcare sector. We have delivered a total of approx. 284,000 products so far this year, an increase by approx. 260 percent. This means that we are already now close to our goal of at least doubling the full-year volumes from 2015. 

November 09, 2016
Regulatory

The main shareholders issue a loan commitment

In order to maintain financial flexibility after the repayment of the bond, and until a long-term financing solution is in place, the main shareholders of Bactiguard have issued a loan commitment of up to SEK 50 million

November 07, 2016

Invitation to presentation of Bactiguard's interim report on November 10, 2016

Bactiguard Holding AB (publ) publishes the interim report for the third quarter on Thursday, November 10, 2016 at 8:00 CET.

November 07, 2016
Regulatory

New major order from China

Bactiguard has received a new major order from China of 100 000 Bactiguard coated Foley catheters for infection prevention.

November 03, 2016
Regulatory

Bactiguard expands in Europe

Bactiguard expands its European presence in four new markets, by entering partnerships with Sanova Pharma for Austria, Pofam-Poznaǹ for Poland, Mediq Suomi for Finland and Inex Medical for Greece. 

November 03, 2016

New endotracheal tube launched

Bactiguard announces the launch of its new BIP Endotracheal Tube Evac, for prevention of ventilator associated pneumonia (VAP). It is one of a kind and designed to offer the best infection protection available on the market. VAP is the second most common nosocomial infection in the ICU, and associated with high-risk pathogens such as MRSA, prolonged hospital stay, increased hospital costs and high patient mortality.

Pages